Clinical trial
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using…
NCT00483327 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00483327 |
|---|---|
| Title | Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate |
| Official title | Prospective Trial of Conservative Management of Atypical Endometrial Hyperplasia and Well to Moderately Differentiated Endometrial Carcinoma Using Megestrol Acetate |
| Lead sponsor | NYU Langone Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atypical Endometrial Hyperplasia, Endometrial Carcinoma |
| Intervention type | Drug |
| Interventions | Megestrol Acetate |
| Enrollment | 31 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2013 |
| Completion | Oct 1, 2013 |
| First posted | Jun 7, 2007 |
| Last update posted | Apr 4, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: